Relay Therapeutics, Inc. RLAY Long-term investments
Long-term investments at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Investments.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s long-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s long-term investments?
- Relay Therapeutics, Inc. (RLAY) reported long-term investments of $437.48M in Q1 2026.
- How has Relay Therapeutics, Inc.'s long-term investments changed year-over-year?
- Relay Therapeutics, Inc.'s long-term investments decreased by 29.1% year-over-year, from $616.81M to $437.48M.
- What is the long-term trend for Relay Therapeutics, Inc.'s long-term investments?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s long-term investments has grown at a 15.3% compound annual growth rate (CAGR), from $230.42M to $470.5M.
- What does long-term investments mean?
- Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.